Table 5.
Exposure | Model I (HR,95%CI, P) | Model II (HR,95%CI, P) | Model III (HR,95%CI, P) |
---|---|---|---|
AST/ALT ratio | 0.79 (0.73, 0.85) <0.0001 | 0.78 (0.73, 0.84) <0.0001 | 0.80 (0.75, 0.85) <0.0001 |
AST/ALT ratio (Quintile) | |||
Q1 | Ref | Ref | Ref |
Q2 | 0.87 (0.80, 0.95) 0.0029 | 0.86 (0.81, 0.91) <0.0001 | 0.87 (0.81, 0.92) <0.0001 |
Q3 | 0.82 (0.74, 0.89) <0.0001 | 0.85 (0.79, 0.91) <0.0001 | 0.85 (0.79, 0.91) <0.0001 |
Q4 | 0.74 (0.67, 0.81) <0.0001 | 0.77 (0.71, 0.84) <0.0001 | 0.77 (0.71, 0.83) <0.0001 |
P for trend | <0.0001 | <0.0001 | <0.0001 |
Model I was sensitivity analysis in participants without BMI≥24kg/m2. We adjusted gender, age, family history of diabetes, drinking status, smoking status, SBP, DBP, BMI, TC, TG, HDL-C, LDL-C, SCr, BUN, FPG.
Model II was sensitivity analysis in participants without age≥60 years. We adjusted gender, age, family history of diabetes, drinking status, smoking status, SBP, DBP, BMI, TC, TG, HDL-C, LDL-C, SCr, BUN, FPG.
Model III was sensitivity analysis in participants without drinker (current-drinker and ex-drinker). We adjusted gender, age, family history of diabetes, smoking status, SBP, DBP, BMI, TC, TG, HDL-C, LDL-C, SCr, BUN, FPG.
HR, hazard ratios; CI, confidence, Ref: reference; AST/ALT ratio: aspartate aminotransferase to alanine aminotransferase ratio.